HUM Humana, Inc. Company Research Saturday, January 11, 2014

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
HUM Humana, Inc. $HUM Company Overview 

Stock Message Board http://investorshangout.com/search?q=HUM&...mp;yt1=Go!

Last Updated: Saturday, January 11, 2014 11:25:02 PM

Humana, Inc. HUM Current Price and Quotes
Last Price 96.96
Previous Close 98.99 Open 97.00
Daily Range 98.77 - 95.01 52wk Range 105.80 - 65.88
Volume 4,074,520 Dividend 1.08
Average Vol (3m) 1,356,345 Yield 1.1139
Humana, Inc. HUM
Company Information

500 West Main Street
Louisville, KY 40202

Phone: 502-580-1000

Humana, Inc. HUM
Not Available

Humana, Inc. HUM
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000049071
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Humana, Inc. HUM
HUM Security Details

Share Structure

Market Value1 $15,117,353,471 a/o Jan 10, 2014
Shares Outstanding 155,913,299 a/o Sep 30, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.1666
Shareholders

Shareholders of Record 5,100 a/o Feb 20, 2009
Security Notes

Latest Addt'l Issue=11-82 3,000,000 shs at $39.125 by Lehman Brothers Kuhn Loeb, Inc.
Capital Change=7-91 shs increased by 3 for 2 split
Short Selling Data

Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)

Mid-America Bank of Louisville and Trust Co.

Humana, Inc. HUM Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 39,126,000 36,832,000 33,596,000 30,743,000
Cost of Revenue 30,985,000 28,823,000 27,117,000 24,784,000
Gross Profit 8,141,000 8,009,000 6,479,000 5,959,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. - - - -
Non-Recurring Items - - - -
Other 6,125,000 5,665,000 4,625,000 4,251,000
Operating Income 2,016,000 2,344,000 1,854,000 1,708,000
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 2,016,000 2,344,000 1,854,000 1,708,000
Interest Expense 105,000 109,000 105,000 106,000
Earnings Before Tax 1,911,000 2,235,000 1,749,000 1,602,000
Income Tax 689,000 816,000 650,000 562,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 1,222,000 1,419,000 1,099,000 1,040,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,222,000 1,419,000 1,099,000 1,040,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,222,000 1,419,000 1,099,000 1,040,000

Humana, Inc. HUM Recent News

Jan 8, 2014 Humana's New MyHumana Mobile App Provides a More Seamless, Integrated Personalized Experience for the Member
Jan 8, 2014 Proliferation of Smartphones Drives the Market for Mobile Medical Apps, According to a New Trend Report Published by Global Industry Analysts, Inc.
Jan 7, 2014 CCC Information Services Acquires Auto Injury Solutions
Jan 7, 2014 Humana Names Fernando J. Valverde, M.D., as Regional President
Jan 6, 2014 Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana
Jan 3, 2014 Humana Executive Named RIMS President for 2014 Term
Jan 3, 2014 Humana Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2014 Humana Inc. to Release Fourth Quarter 2013 Results on February 5, 2014
Jan 2, 2014 Humana Names Chris Hunter Senior Vice President and Chief Strategy Officer
Dec 27, 2013 Pre-Market Technical Briefing: UnitedHealth Group, Aetna, WellPoint, and Humana

1
2
3
4
5
next >

HUM Humana, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=HUM&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/HUM/quote
Stock Chart http://www.otcmarkets.com/stock/HUM/chart
Company Info http://www.otcmarkets.com/stock/HUM/company-info
Recent News http://www.otcmarkets.com/stock/HUM/news
Financials http://www.otcmarkets.com/stock/HUM/financials
Filings and Disclosure http://www.otcmarkets.com/stock/HUM/filings
Short Sales http://www.otcmarkets.com/stock/HUM/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/HUM/insider-transactions
Research Reports http://www.otcmarkets.com/stock/HUM/research
Summary http://finance.yahoo.com/q?s=HUM
Historical Prices http://finance.yahoo.com/q/hp?s=HUM+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=HUM
Basic Chart http://finance.yahoo.com/q/bc?s=HUM+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HUM+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=HUM+Headlines
Press Releases http://finance.yahoo.com/q/p?s=HUM+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=HUM+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=HUM+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=HUM+Industry
Major Holders http://finance.yahoo.com/q/mh?s=HUM+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=HUM+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=HUM+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=HUM
Balance Sheet http://finance.yahoo.com/q/bs?s=HUM
Cash Flow http://finance.yahoo.com/q/cf?s=HUM+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/HUM
Market Watch http://www.marketwatch.com/investing/stock/HUM
Bloomberg http://www.bloomberg.com/quote/HUM:US
Morningstar http://quotes.morningstar.com/stock/s?t=HUM
Bussinessweek http://investing.businessweek.com/research/st...ticker=HUM
Barchart http://www.barchart.com/quotes/stocks/HUM
OTC Short Report http://otcshortreport.com/index.php?index=HUM
Investopedia http://www.investopedia.com/markets/stocks/HUM/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading